You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

14-017

Showing 1 - 25 of 9,930
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (BEA 2180 BR, Tiotropium Bromide, Placebo)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • BEA 2180 BR
  • +2 more
  • Jasper, Alabama
  • +177 more
Jul 30, 2021

Coronary Artery Disease Trial in Worldwide (Inclisiran sodium 300 mg, Placebo)

Recruiting
  • Coronary Artery Disease
  • Inclisiran sodium 300 mg
  • Placebo
  • Huntsville, Alabama
  • +54 more
Jan 31, 2023

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

Recruiting
  • Solid Tumor
  • Hematological Malignancy
  • East Melbourne, Victoria, Australia
  • +4 more
Jan 11, 2023

Malaria Trial in Kumasi, Kisumu (RTS,S/AS01E (Full dose), RTS,S/AS01E (1/5th dose), Rabies vaccine)

Completed
  • Malaria
  • RTS,S/AS01E (Full dose)
  • +2 more
  • Kumasi, Ghana
  • +1 more
Jan 24, 2023

Wounds and Injuries, Lacerations, Surgical Incision Trial in Worldwide (MAR-CUTIS, Dermabond Advanced)

Terminated
Has Results
  • Wounds and Injuries
  • +2 more
  • MAR-CUTIS
  • Dermabond Advanced
  • Amiens, France
  • +18 more
Aug 10, 2020

Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

Active, not recruiting
  • Hodgkin Lymphoma Survivor
  • Clinical Assessment
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 22, 2022

Advanced NSCLC, Metastatic Lung Cancer Trial in East Syracuse, Cleveland, Bellingham (Adagrasib in combination with

Recruiting
  • Advanced NSCLC
  • Metastatic Lung Cancer
  • Adagrasib in combination with pembrolizumab
  • Pembrolizumab
  • East Syracuse, New York
  • +2 more
Nov 28, 2022

Heart Failure With Preserved Ejection Fraction, Beta Blocker, Myocardial Strain Trial in Seoul, Wonju (Carvedilol, Placebo)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • +2 more
  • Seoul, Il-won, Korea, Republic of
  • +1 more
Oct 18, 2022

Subarachnoid Hemorrhage, Aneurysmal Trial (Shuxuening injection or )

Not yet recruiting
  • Subarachnoid Hemorrhage, Aneurysmal
  • Shuxuening injection or placebo
  • (no location specified)
Nov 18, 2023

Severe Illness, Septicaemia, Diarrhoea Trial in Kampala (BCG at birth, Control arm: Delayed BCG)

Recruiting
  • Severe Illness
  • +3 more
  • BCG at birth
  • Control arm: Delayed BCG
  • Kampala, Uganda
    Health Centers in Mukono and Kampala districts
Aug 24, 2022

CT-based Myocardial Characterization (CTMyoC)

Recruiting
  • Different Cardiomyopathy and Major Cardiovascular Adverse Events
    • Milano, Italy
      IRCCS San Raffaele
    Sep 1, 2023

    Surgical Wound Trial (PICO 7, PICO 14)

    Not yet recruiting
    • Surgical Wound
    • PICO 7
    • PICO 14
    • (no location specified)
    May 20, 2022

    Digestive System Disease, Sleepiness, Crying Trial in Jinhua (a2 Full Cream Milk, Conventional Milk (Weidendorf))

    Not yet recruiting
    • Digestive System Disease
    • +2 more
    • a2 Full Cream Milk
    • Conventional Milk (Weidendorf)
    • Jinhua, Zhejiang, China
    • +1 more
    Apr 13, 2023

    HIV Trial in Worldwide (Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet), Rectal Daily TFV RG 1% gel

    Completed
    Has Results
    • HIV
    • Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet)
    • +2 more
    • San Francisco, California
    • +7 more
    Jun 22, 2021

    ICU Delirium Trial in Taipei (mHELP@ICU)

    Recruiting
    • ICU Delirium
    • mHELP@ICU
    • Taipei, National Taiwan University, Taiwan
      Cheryl, Chia-Hui Chen, PhD
    Sep 19, 2023

    ASCVD, Risk Factor, Cardiovascular, Elevated Cholesterol Trial in Worldwide (Inclisiran Sodium, Placebo)

    Completed
    Has Results
    • ASCVD
    • +2 more
    • Inclisiran Sodium
    • Placebo
    • Chomutov, Czechia
    • +69 more
    Aug 3, 2020

    Autism Spectrum Disorder Trial in Bloomington (Virtual reality active video gaming using Nintendo switch sports, Standard

    Recruiting
    • Autism Spectrum Disorder
    • Virtual reality active video gaming using Nintendo switch sports
    • Standard physical therapy balance exercises
    • Bloomington, Indiana
      Indiana University Bloomington
    Aug 29, 2023

    Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

    Recruiting
    • Mycobacterium Infections, Nontuberculous
    • Birmingham, Alabama
    • +172 more
    Jan 23, 2023

    Atopic Dermatitis, Atopic Dermatitis Eczema Trial (Lactic acid bacteria NTU 101, Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • Atopic Dermatitis Eczema
    • Lactic acid bacteria NTU 101
    • Placebo
    • (no location specified)
    Jan 30, 2023

    Renal Anemia Trial in China, United States (AND017, Placebo)

    Recruiting
    • Renal Anemia
    • Northridge, California
    • +7 more
    Jul 5, 2022

    Apparently Healthy Adults and Chronic, Stable Morbidities

    Recruiting
    • Healthy
    • Chronic Disease
    • Urine collection for NEPHROCLEAR CCL14 Test
    • Gresham, Oregon
      Cyn3rgy Research
    May 1, 2023

    Fragile X Syndrome Trial in Australia, New Zealand, United States (ZYN002 - Cannabidiol Transdermal Gel)

    Enrolling by invitation
    • Fragile X Syndrome
    • ZYN002 - Cannabidiol Transdermal Gel
    • Phoenix, Arizona
    • +21 more
    Aug 18, 2022

    Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 30, 2022